HTG Completes its Initial Public Offering

San Diego – May 20, 2015 – Cooley advised HTG Molecular Diagnostics, Inc. on its initial public offering. HTG is a commercial stage company that develops and markets a novel technology platform to facilitate the routine use of complex molecular profiling. The company trades on The NASDAQ Global Market under the symbol "HTGM."

The Cooley corporate securities team advising HTG included partners Wainwright Fishburn and Steve Przesmicki and associates Wade Andrews, Asa Henin, Matt Robbins and Sunny Chang.

Support for the offering was provided by partners Natasha Leskovsek and Wendy Goldstein and special counsel Phil Mitchell (health care and life sciences regulatory); partner Susan Cooper Philpot, senior counsel Bill Morrow and associate Todd Gluth (tax); and associate Megan Arthur (compensation and benefits).

About Cooley LLP

Cooley's lawyers solve legal issues for entrepreneurs, investors, financial institutions and established companies. Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, often where innovation meets the law.

Cooley has 850 lawyers across 12 offices in the United States, China and Europe.

Related Contacts
Susan Cooper Philpot Partner, San Francisco
Bill Morrow Retired Partner, San Diego
Steve Przesmicki Partner, San Diego
Megan Arthur Schilling Partner, San Diego
Natasha Leskovsek Partner, Washington, DC
Wainwright Fishburn Partner, San Diego
Wade Andrews Associate, San Diego
Asa Henin Associate, San Diego
Matt Robbins Associate, San Diego
Phil Mitchell Partner, New York
Todd Gluth Partner, San Diego
Sunny Chang Associate, San Diego